skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Updated Trends in Cancer in Japan: Incidence in 1985–2015 and Mortality in 1958–2018—A Sign of Decrease in Cancer Incidence

Journal of epidemiology, 2021-07, Vol.31 (7), p.426-450, Article JE20200416 [Peer Reviewed Journal]

2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Kota Katanoda et al. 2021 Kota Katanoda et al ;ISSN: 0917-5040 ;EISSN: 1349-9092 ;DOI: 10.2188/jea.JE20200416 ;PMID: 33551387

Full text available

Citations Cited by
  • Title:
    Updated Trends in Cancer in Japan: Incidence in 1985–2015 and Mortality in 1958–2018—A Sign of Decrease in Cancer Incidence
  • Author: Katanoda, Kota ; Hori, Megumi ; Saito, Eiko ; Shibata, Akiko ; Ito, Yuri ; Minami, Tetsuji ; Ikeda, Sayaka ; Suzuki, Tatsuya ; Matsuda, Tomohiro
  • Subjects: Adenomatous polyposis coli ; Age ; Breast ; Cancer ; Confidence intervals ; Females ; incidence ; Males ; Mortality ; neoplasms ; Original ; population surveillance ; Prostate ; Regression analysis ; Statistical analysis ; Trends ; Vital statistics
  • Is Part Of: Journal of epidemiology, 2021-07, Vol.31 (7), p.426-450, Article JE20200416
  • Description: Background: Unlike many North American and European countries, Japan has observed a continuous increase in cancer incidence over the last few decades. We examined the most recent trends in population-based cancer incidence and mortality in Japan. Methods: National cancer mortality data between 1958 and 2018 were obtained from published vital statistics. Cancer incidence data between 1985 and 2015 were obtained from high-quality population-based cancer registries maintained by three prefectures (Yamagata, Fukui, and Nagasaki). Trends in age-standardized rates (ASR) were examined using Joinpoint regression analysis. Results: For males, all-cancer incidence increased between 1985 and 1996 (annual percent change [APC] +1.1%; 95% confidence interval [CI], 0.7–1.5%), increased again in 2000–2010 (+1.3%; 95% CI, 0.9–1.8%), and then decreased until 2015 (−1.4%; 95% CI, −2.5 to −0.3%). For females, all-cancer incidence increased until 2010 (+0.8%; 95% CI, 0.6–0.9% in 1985–2004 and +2.4%; 95% CI, 1.3–3.4% in 2004–2010), and stabilized thereafter until 2015. The post-2000 increase was mainly attributable to prostate in males and breast in females, which slowed or levelled during the first decade of the 2000s. After a sustained increase, all-cancer mortality for males decreased in 1996–2013 (−1.6%; 95% CI, −1.6 to −1.5%) and accelerated thereafter until 2018 (−2.5%; 95% CI, −2.9 to −2.0%). All-cancer mortality for females decreased intermittently throughout the observation period, with the most recent APC of −1.0% (95% CI, −1.1 to −0.9%) in 2003–2018. The recent decreases in mortality in both sexes, and in incidence in males, were mainly attributable to stomach, liver, and male lung cancers. Conclusion: The ASR of all-cancer incidence began decreasing significantly in males and levelled off in females in 2010.
  • Publisher: Fukuoka: Japan Epidemiological Association
  • Language: English
  • Identifier: ISSN: 0917-5040
    EISSN: 1349-9092
    DOI: 10.2188/jea.JE20200416
    PMID: 33551387
  • Source: GFMER Free Medical Journals
    PubMed Central
    ProQuest Central
    DOAJ Directory of Open Access Journals

Searching Remote Databases, Please Wait